No matter how cynical the overall market is TG Therapeutics Inc. (TGTX) performance over the last week is recorded -11.57%

As on May 24, 2023, TG Therapeutics Inc. (NASDAQ: TGTX) started slowly as it slid -2.75% to $27.97. During the day, the stock rose to $28.5499 and sunk to $27.6515 before settling in for the price of $28.76 at the close. Taking a more long-term approach, TGTX posted a 52-week range of $3.48-$35.67.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 78.80%. Meanwhile, its Annual Earning per share during the time was 5.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 44.40%. This publicly-traded company’s shares outstanding now amounts to $140.31 million, simultaneously with a float of $133.34 million. The organization now has a market capitalization sitting at $4.27 billion. At the time of writing, stock’s 50-day Moving Average stood at $23.00, while the 200-day Moving Average is $13.10.

While finding the extent of efficiency of the company that is accounted for 237 employees. It has generated 12,323 per worker during the last fiscal year. Meanwhile, its income per employee was -877,588. The stock had 4.01 Receivables turnover and 0.01 Total Asset turnover. For the Profitability, stocks gross margin was +71.99, operating margin was -6924.20 and Pretax Margin of -7121.54.

TG Therapeutics Inc. (TGTX) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. TG Therapeutics Inc.’s current insider ownership accounts for 1.10%, in contrast to 69.70% institutional ownership. According to the most recent insider trade that took place on Jan 06, this organization’s Director bought 9,000 shares at the rate of 10.64, making the entire transaction reach 95,760 in total value, affecting insider ownership by 201,848. Preceding that transaction, on Jan 04, Company’s Director sold 30,000 for 11.10, making the whole transaction’s value amount to 333,000. This particular insider is now the holder of 234,729 in total.

TG Therapeutics Inc. (TGTX) Earnings and Revenue Records

If we go through the results of last quarter, which was made public on 3/30/2023, the company posted -$0.28 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.37) by $0.09. This company achieved a net margin of -7121.54 while generating a return on equity of -134.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.

TG Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 44.40% and is forecasted to reach -0.46 in the upcoming year.

TG Therapeutics Inc. (NASDAQ: TGTX) Trading Performance Indicators

Let’s observe the current performance indicators for TG Therapeutics Inc. (TGTX). It’s Quick Ratio in the last reported quarter now stands at 2.50. The Stock has managed to achieve an average true range (ATR) of 1.81. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 497.09.

In the same vein, TGTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.23, a figure that is expected to reach -0.27 in the next quarter, and analysts are predicting that it will be -0.46 at the market close of one year from today.

Technical Analysis of TG Therapeutics Inc. (TGTX)

Through scrutinizing the latest numbers posted by the [TG Therapeutics Inc., TGTX], it can be observed that its last 5-days Average volume of 2.62 million was lower the volume of 4.55 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 4.01% While, its Average True Range was 1.77.

Raw Stochastic average of TG Therapeutics Inc. (TGTX) in the period of the previous 100 days is set at 70.00%, which indicates a major rise in contrast to 4.15% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 55.74% that was lower than 91.68% volatility it exhibited in the past 100-days period.